F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs

Health
By Christina Jewett and Rebecca Robbins from NYT Health https://ift.tt/mFPZKex
via IFTTT Regulation and Deregulation of Industry, Drugs (Pharmaceuticals), Letters The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda